Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells
- PMID: 15324818
- DOI: 10.1016/j.chembiol.2004.06.006
Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells
Abstract
RNA interference (RNAi) is the process by which short-interfering RNA (siRNA) target a specific mRNA for degradation through interactions with an RNA-induced silencing complex (RISC). Here, a clear correlation between siRNA localization, cellular uptake, and RNAi activity was discovered by delivering siRNA into cells using siRNA-TAT(47-57) peptide, siRNA-TAT(47-57)-derived oligocarbamate conjugates, or nanoparticles. For successful RNAi, the localization of siRNA was distinctly perinuclear, suggesting that siRNA is targeted to these regions for interactions with RISC to induce RNAi. siRNA sequence variation and the presence of the target mRNA apparently did not change the subcellular localization pattern of siRNA. Intriguingly, siRNA conjugated to TAT(47-57) peptide or TAT(47-57)-derived oligocarbamate resulted in efficient RNAi activity and perinuclear localization of siRNA that was distinctly different from nonconjugated free TAT peptide nucleolar localization. These results suggest that interactions with RISC dictate siRNA localization even when siRNA is conjugated to TAT(47-57) peptide.
Similar articles
-
Delivery of therapeutic shRNA and siRNA by Tat fusion peptide targeting BCR-ABL fusion gene in Chronic Myeloid Leukemia cells.J Control Release. 2010 Aug 3;145(3):272-80. doi: 10.1016/j.jconrel.2010.04.011. Epub 2010 Apr 24. J Control Release. 2010. PMID: 20403398
-
Competition potency of siRNA is specified by the 5'-half sequence of the guide strand.Biochem Biophys Res Commun. 2008 Feb 29;367(1):78-83. doi: 10.1016/j.bbrc.2007.12.099. Epub 2007 Dec 27. Biochem Biophys Res Commun. 2008. PMID: 18164261
-
Dissecting RNA-interference pathway with small molecules.Chem Biol. 2005 Jun;12(6):643-8. doi: 10.1016/j.chembiol.2005.04.016. Chem Biol. 2005. PMID: 15975509
-
[Great potential of small RNAs: RNA interference and microRNA].Rev Invest Clin. 2006 Jul-Aug;58(4):335-49. Rev Invest Clin. 2006. PMID: 17146945 Review. Spanish.
-
HIV-1-specific RNA interference.Curr Opin Mol Ther. 2004 Aug;6(4):373-80. Curr Opin Mol Ther. 2004. PMID: 15468596 Review.
Cited by
-
Delivery of therapeutic RNAi by nanovehicles.Chembiochem. 2009 Oct 12;10(15):2449-54. doi: 10.1002/cbic.200900252. Chembiochem. 2009. PMID: 19688785 Free PMC article. Review. No abstract available.
-
Aptamer-targeted cell-specific RNA interference.Silence. 2010 Feb 1;1(1):4. doi: 10.1186/1758-907X-1-4. Silence. 2010. PMID: 20226078 Free PMC article.
-
Phage protein-targeted cancer nanomedicines.FEBS Lett. 2014 Jan 21;588(2):341-9. doi: 10.1016/j.febslet.2013.11.011. Epub 2013 Nov 20. FEBS Lett. 2014. PMID: 24269681 Free PMC article. Review.
-
Novel fusion peptide-mediated siRNA delivery using self-assembled nanocomplex.J Nanobiotechnology. 2021 Feb 12;19(1):44. doi: 10.1186/s12951-021-00791-x. J Nanobiotechnology. 2021. PMID: 33579303 Free PMC article.
-
Small interfering RNA-induced TLR3 activation inhibits blood and lymphatic vessel growth.Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7137-42. doi: 10.1073/pnas.0812317106. Epub 2009 Apr 9. Proc Natl Acad Sci U S A. 2009. PMID: 19359485 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous